Health Care/Hospital

Converging at BIO, ACROBiosystems Connects Emerging Innovation Assets with Global Strategic Opportunities

SAN DIEGO, July 13, 2026 /PRNewswire/ -- Ahead of the BIO International Convention, BIOSeedin Summer Innovation Partnering Summit was successfully held at Wyndham San Diego Bayside, California. Hosted by bioSeedin, the summit's discussion topics were about early-stage innovation assets, late-stag...

2026-07-14 00:00 4486

HKEY-AI-NAM-Bridge™ 1.0: HKeyBio Connects AI, NAMs and In Vivo Evidence

HKEY-AI-NAM-Bridge™ 1.0 connects AI predictions, new approach methodologies and in vivo evidence for more targeted preclinical study design BOSTON and SUZHOU, China, July 13, 2026 /PRNewswire/ -- HKeyBio has establishedHKEY-AI-NAM-Bridge™ 1.0, its AI and New Approach Methodologies (NAMs) In Vivo...

2026-07-13 21:16 3747

IMG Opens Applications for 2026 Fall Semester 'Student Journey Scholarship'

INDIANAPOLIS, July 13, 2026 /PRNewswire/ -- IMG (International Medical Group) is now accepting applications for itsStudent Journey Scholarship

2026-07-13 21:00 3024

Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business

* Acquisition supports Servier's strategic ambition in rare neurology with sevasemten, a late-stage investigational treatment for Becker and Duchenne muscular dystrophies.   * The acquired asset and expert team strengthen Servier's commitment to innovate for patients with high unmet medical ...

2026-07-13 20:30 2400

Delonix Bioworks Announces First Participant Dosed in Phase 1 Clinical Trial of Next-Generation MenB OMV Vaccine DX-104 in China

SHANGHAI, July 13, 2026 /PRNewswire/ -- Delonix Bioworks, a clinical-stage biotechnology company pioneering genetically engineered bacterial vaccines, today announced that the first participant has been dosed in its Phase 1 clinical trial of DX-104 in China. DX-104 is an innovative Group B menin...

2026-07-13 20:00 3383

POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement

GUANGZHOU, China, July 13, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthcare capabilities, today announced that on July 10, 2026, the Company received a ...

2026-07-13 20:00 3215

Advancing Low-Carbon Manufacturing and Global Sustainability Commitments

Report highlights clean energy, innovation and ESG recognition ZIBO, China, July 13, 2026 /PRNewswire/ -- INTCO Medical  ("the Company"), a leading global manufacturer of disposable gloves, has released its 2025 Environmental, Social and Governance (ESG) Report, ou...

2026-07-13 17:19 4672

Leads Biolabs Announces Multiple Studies Selected for ESMO 2026, Highlighting the Growing Global Competitiveness of Its Core Pipeline

NANJING, China, July 13, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that six of its latest research studies have been accepted for presentation at the 2026 European Society for Medical Oncology (ESMO) Annual Congres...

2026-07-13 16:56 4380

Boostimmune Secures Japanese Patent for Sequence-Independent TCTP Antibody Technology Targeting MDSC Accumulation

* Japanese patent granted for technology that inhibits TCTP released from dead tumor cells using antibodies to suppress the accumulation of MDSCs in the tumor microenvironment * Granted claims are not expressly limited to specific antibody CDRs or amino acid sequences, but are defined by func...

2026-07-13 16:53 2801

KLN Signs MOU with Advantech and YDCare to Support Digital Transformation of Hong Kong's Healthcare System

HONG KONG, July 13, 2026 /PRNewswire/ -- KLN Logistics Group Limited ('KLN'; Stock Code 0636.HK) announced that its healthcare subsidiary, KLN Medical Limited ('KLN Medical'), has signed a tripartite Memorandum of Understanding (MOU) with Advantech Co., Ltd. ('Advantech'; Stock Code 2395.TW), a g...

2026-07-13 12:19 3352

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2026 LIFESTYLE PROGRAM IMPROVES BRAIN HEALTH AMONG OLDER ADULTS AT RISK FOR DEMENTIA ACROSS LATIN AMERICA

- LatAm-FINGERS Study Findings Confirm and Expand U.S. POINTER Trial Results - - Show Structured Dementia Risk Reduction Strategies Adaptable Across Cultures - Key Takeaways * The LatAm-FINGERS study shows lifestyle interventions adapted across Latin American cultures, health systems and commu...

2026-07-13 12:01 3065

Antengene Announces Receipt of USD 60 Million Upfront Payment from UCB

SHANGHAI and HONG KONG, July 13, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune dis...

2026-07-13 12:00 3834

AbbVie Employees Across Asia Unite Through Week of Possibilities by Serving and Supporting Communities

* 873 employees volunteered more than 3,600 hours across 7 Asian markets to support local communities. * Employees partnered with 21 community organizations, positively impacting more than 4,300 people through initiatives focused on patient support, inclusion, education and environmental su...

2026-07-13 10:00 2889

Deepening Collaboration in AI-Powered R&D Acceleration: Insilico Medicine and CMS announce additional collaborations in CNS diseases

SHANGHAI, July 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI),and China Medical System Holdings Limited ("CMS", 867.HK/8A8.SG), an open-platform innovative company linking pharmaceutical ...

2026-07-13 08:30 3917

AIA ANNOUNCES WINNERS OF THE AIA HEALTHIEST SCHOOLS COMPETITION

HONG KONG, July 13, 2026 /PRNewswire/ -- AIA Group Limited ("AIA" or the "Group") is proud to unveil the winners of the fourth annualAIA Healthiest Schools Competition, a flagship initiative of the AIA Healthiest Schools programme ("AHS") which empowers students aged five to 16 to turn healthy l...

2026-07-13 08:00 2753

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2026

FORMER ELITE SOCCER PLAYERS SHOW EVIDENCE OF BRAIN HEALTH CHANGES IN MID-LIFE Key Takeaways * New research provides insights into brain health among former elite professional soccer players during midlife. * Former players reported high levels of depression, anxiety, and subjective difficult...

2026-07-12 12:01 3730

Smartee S22: Incorporating GS MART Technology into Occlusal Reconstructive Therapy in Prosthodontics

SHENZHEN, China, July 10, 2026 /PRNewswire/ -- Smartee Denti-Technology has announced the launch of S22: GS MART (Mandibular Repositioning Technology) for Occlusal Reconstruction in Prosthodontic Dentistry, expanding the clinical application of its GS MART into prosthodontic dentistry. The projec...

2026-07-10 18:07 5473

Puncture Robotic Showcases AI-Powered Hair Restoration Innovation at WCHR 2026

SEOUL, South Korea, July 10, 2026 /PRNewswire/ -- Artificial intelligence is rapidly reshaping medical aesthetics, and hair restoration is undergoing a significant technological transformation. At the 14th World Congress for Hair Research (WCHR 2026), Puncture Robotic attracted international atte...

2026-07-10 17:47 4778

Medical AI Ecosystem Innovation Forum and iMedLoop Global Medical Imaging Data Platform Launch Held in Beijing

When Healthcare Meets AI: A New Era of Ecosystem-wide Innovation Is Accelerating BEIJING, July 10, 2026 /PRNewswire/ -- On July 4, the Medical AI Ecosystem Innovation Forum and iMedLoop Global Medical Imaging Data Platform Launch was held in Beijing. Jointly organized by Liaowang Finance, under ...

2026-07-10 17:04 5661

Priority Review Granted to PD-L1/4-1BB Bispecific Antibody Opamtistomig, Accelerating Commercialization and Addressing Unmet Need in EP-NEC

NANJING, China, July 10, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that the biologics license application (BLA) for Opamtistomig (LBL-024, a PD-L1/4-1BB bispecific antibody) as monotherapy for the treatment of adva...

2026-07-10 16:53 5260
1 ... 41424344454647 ... 845

Week's Top Stories